SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001439222-19-000009
Filing Date
2019-05-02
Accepted
2019-05-02 08:57:30
Documents
76
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q agio-20190331.htm   iXBRL 10-Q 1530107
2 EXHIBIT 31.1 exhibit31-1x03x31x19.htm EX-31.1 11894
3 EXHIBIT 31.2 exhibit31-2x03x31x19.htm EX-31.2 11305
4 EXHIBIT 32.1 exhibit32-1x03x31x19.htm EX-32.1 7017
5 EXHIBIT 32.2 exhibit32-2x03x31x19.htm EX-32.2 6401
  Complete submission text file 0001439222-19-000009.txt   6324935

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agio-20190331.xsd EX-101.SCH 56930
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agio-20190331_cal.xml EX-101.CAL 90166
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agio-20190331_def.xml EX-101.DEF 195658
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agio-20190331_lab.xml EX-101.LAB 524568
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agio-20190331_pre.xml EX-101.PRE 372409
11 EXTRACTED XBRL INSTANCE DOCUMENT agio-20190331_htm.xml XML 1008749
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS INC (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 19789971
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences